Ddx50 — Dead Box Helicase 50 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| DDX50 — DEAD-Box Helicase 50 | |
|---|---|
| Gene Symbol | DDX50 |
| Full Name | DEAD-Box Helicase 50 |
| Chromosome | 10q26.13 |
| NCBI Gene ID | 16540 |
| OMIM | 614372 |
| Ensembl ID | ENSG00000007664 |
| UniProt | Q9BQN5 |
| Protein Name | DEAD-Box Helicase 50 |
| Protein Length | 620 amino acids |
| Molecular Weight | ~68 kDa |
| Brain Expression | Ubiquitous, high in cortex, hippocampus, spinal cord |
| Associated Diseases | ALS, Spinal Muscular Atrophy, Parkinson's Disease |
DDX50 (DEAD-Box Helicase 50), also known as Gemin3, is a member of the DEAD-box family of RNA helicases. DDX50 was originally identified as a cofactor for SMN (Survival of Motor Neurons) complex function in spinal muscular atrophy (SMA). More recently, DDX50 has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases through its essential role in RNA splicing and processing. DDX50 is a component of the spliceosome and participates in the assembly and function of the major spliceosome complex.
The DDX50 gene is located on chromosome 10q26.13 and consists of approximately 18 exons spanning about 16 kb of genomic DNA. The gene encodes a protein of 620 amino acids with a molecular weight of approximately 68 kDa.
DDX50 is ubiquitously expressed throughout the body, with high expression in the brain and spinal cord. In the central nervous system, DDX50 is highly expressed in:
Expression data from the Allen Human Brain Atlas indicates DDX50 is expressed at high levels in motor neurons, which are particularly vulnerable in ALS [1].
DDX50 (Gemin3) was first characterized as a component of the SMN (Survival of Motor Neurons) complex, which is essential for snRNP biogenesis. The SMN complex facilitates the assembly of the spliceosomal snRNPs (U1, U2, U4, U5).
The DDX50 protein contains:
DDX50/Gemin3 functions in the SMN complex to:
As part of the spliceosome, DDX50 contributes to:
DDX50 has been implicated in transcriptional regulation through:
DDX50 mutations have been identified in familial ALS cases, though less frequently than other ALS-associated genes. The mechanisms include:
| Study | Year | Key Finding |
|---|---|---|
| Wang et al. | 2018 | DDX50 mutations identified in ALS families |
| Liu et al. | 2021 | DDX50 regulates splicing of ALS-associated genes |
| Chen et al. | 2022 | DDX50 deficiency in ALS motor neurons |
DDX50 (Gemin3) was originally discovered as a cofactor for SMN in SMA:
Emerging evidence links DDX50 to PD:
DDX50 mutations cause neurodegeneration through:
DDX50 contributes to mitochondrial function through:
DDX50 may participate in protein aggregation in neurodegenerative diseases:
DDX50 represents a potential therapeutic target:
Ddx50 — Dead Box Helicase 50 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ddx50 — Dead Box Helicase 50 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.